Cargando…
Celecoxib concentration predicts decrease in prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk women
BACKGROUND: Epidemiologic studies suggest that long term low dose celecoxib use significantly lowers breast cancer risk. We previously demonstrated that 400 mg celecoxib taken twice daily for 2 weeks lowered circulating plasma and breast nipple aspirate fluid (NAF) prostaglandin (PG)E(2 )concentrati...
Autores principales: | Sauter, Edward R, Qin, Wenyi, Hewett, John E, Ruhlen, Rachel L, Flynn, John T, Rottinghaus, George, Chen, Yin-Chieh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259321/ https://www.ncbi.nlm.nih.gov/pubmed/18267025 http://dx.doi.org/10.1186/1471-2407-8-49 |
Ejemplares similares
-
Celecoxib decreases prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer
por: Sauter, Edward R, et al.
Publicado: (2006) -
uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
por: Qin, Wenyi, et al.
Publicado: (2008) -
Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy
por: Qin, Wenyi, et al.
Publicado: (2012) -
Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy
por: Deutscher, Susan L, et al.
Publicado: (2010) -
Nipple Aspirate Fluid at a Glance
por: Patuleia, Susana I. S., et al.
Publicado: (2021)